The co-translational “cleavage” of diabody chains by the 2A self-cleaving peptide and subsequently augmented production and secretion of assembled diabodies by genetically engineered human cells led to the improved binding of the bsAb to the antigen (CEA) and enhanced T cell cytotoxicity against CEA-positive tumor cells.37 This evidence concerns the gene CEACAM5 and neoplasm.